Epilepsy Research
Volume 30, Issue 1 , Pages 31-40, March 1998

A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures

  • Reetta Kälviäinen

      Affiliations

    • Department of Neurology, University Hospital of Kuopio, Kuopio, Finland
    • Corresponding Author InformationCorresponding author. Tel.: +358 17 173311; fax: +358 17 173031.
    • ,
  • Martin J Brodie

      Affiliations

    • Epilepsy Unit, University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, UK
    • ,
  • John Duncan

      Affiliations

    • Chalfont Centre for Epilepsy, Buckinghamshire, UK
    • ,
  • David Chadwick

      Affiliations

    • Department of Neurological Science, The Walton Centre for Neurology and Neurosurgery, University of Liverpool, Liverpool, UK
    • ,
  • David Edwards

      Affiliations

    • Novo Nordisk A/S, Bagsvaerd, Denmark
    • ,
  • Karsten Lyby

      Affiliations

    • Novo Nordisk A/S, Bagsvaerd, Denmark
    • ,
  • for the Northern European Tiagabine Study Group

Received 20 September 1997; accepted 10 October 1997.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0920-1211(97)00082-X

Epilepsy Research
Volume 30, Issue 1 , Pages 31-40, March 1998

Article Tools

* Image Usage & Resolution